| Company* (Country; Symbol) |
Company* (Country; Symbol) |
Type/Product Area | Terms/Details (Date) |
| Cardium Therapeutics Inc. (AMEX:CXM) | Koninklijke Philips Electronics NV (the Netherlands) | Asset purchase agreement for the acquisition of Cardium's InnerCool therapies business | Philips bought the business for $11.25M plus $1.5M in trade payables (7/15) |
| Lorus Therapeutics Inc. (Canada; TSX:LOR) | Erin Mills Investment Corp. | Agreement for Lorus to buy back $9.7M in secured convertible debentures in a deal that gives Mills rights to Virulizin for cancer | Lorus gets half of the royalties received under the 2008 licensing agreement with Zor Pharmaceuticals Inc., and has a license for the use of Virulizin in animals (6/23) |
|
Notes: * Private companies are indicated with an asterisk. Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.AMEX = American Stock Exchange; TSX = Toronto Stock Exchange. | |||
